大葉大學圖書館 |

Immunotherapy of melanoma[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.9947706
書名/作者:	Immunotherapy of melanoma/ by Anand Rotte, Madhuri Bhandaru.
作者:	Rotte, Anand.
其他作者:	Bhandaru, Madhuri.
出版者:	Cham : : Springer International Publishing :, 2016.
面頁冊數:	xi, 434 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Melanoma - Immunotherapy.
標題:	Melanoma - Immunological aspects.
標題:	Medicine.
標題:	Cancer - Research.
標題:	Oncology.
標題:	Biomedicine.
標題:	Cancer Research.
ISBN:	9783319480664
ISBN:	9783319480657
內容註:	Preface -- Melanoma -- Tumor immunology -- Immune based drugs approved for treatment of melanoma -- Promising immunotherapeutic approaches in clinical trials -- Challenges of immunotherapy -- Index.
摘要、提要註:	This book focusses on the different types of immunotherapeutics that are currently being used and developed for the treatment of melanoma. In recent years, immunotherapy has revolutionized the treatment of metastatic melanoma and other types of cancer. Discussing treatment options for melanoma and the success of immunotherapy along with the challenges of immunotherapy, this book covers epidemiology, susceptibility genes, and treatment recommendations from Society for Immunotherapy of Cancer, as well as immune based therapies such as aldesleukin, Intron-A, Sylatron, Yervoy, Opdivo, Keytruda, Imlygic, DC vaccines and adoptive cell therapy. The detailed information included on the key immune cells involved in anti-tumor immune response and immune-inhibitory mechanisms in tumor microenvironment will aid the understanding of tumor immunology. Both academic as well as industry-based researchers, developing novel anti-cancer therapies, will also benefit from the details of promising molecular targets and immunotherapeutic strategies under investigation. With 132 illustrations including synopsis tables for important information, over 1200 references (majority of which are openly accessible) and details of more than 150 ongoing clinical trials, this book is a valuable source of information for health care providers as well as cancer biologists interested in learning about melanoma and the significant advances made by immunotherapy.
電子資源:	http://dx.doi.org/10.1007/978-3-319-48066-4

Immunotherapy of melanoma[electronic resource] /
Rotte, Anand.

Immunotherapy of melanoma[electronic resource] /by Anand Rotte, Madhuri Bhandaru. - Cham :Springer International Publishing :2016. - xi, 434 p. :ill., digital ;24 cm.

Preface -- Melanoma -- Tumor immunology -- Immune based drugs approved for treatment of melanoma -- Promising immunotherapeutic approaches in clinical trials -- Challenges of immunotherapy -- Index.

This book focusses on the different types of immunotherapeutics that are currently being used and developed for the treatment of melanoma. In recent years, immunotherapy has revolutionized the treatment of metastatic melanoma and other types of cancer. Discussing treatment options for melanoma and the success of immunotherapy along with the challenges of immunotherapy, this book covers epidemiology, susceptibility genes, and treatment recommendations from Society for Immunotherapy of Cancer, as well as immune based therapies such as aldesleukin, Intron-A, Sylatron, Yervoy, Opdivo, Keytruda, Imlygic, DC vaccines and adoptive cell therapy. The detailed information included on the key immune cells involved in anti-tumor immune response and immune-inhibitory mechanisms in tumor microenvironment will aid the understanding of tumor immunology. Both academic as well as industry-based researchers, developing novel anti-cancer therapies, will also benefit from the details of promising molecular targets and immunotherapeutic strategies under investigation. With 132 illustrations including synopsis tables for important information, over 1200 references (majority of which are openly accessible) and details of more than 150 ongoing clinical trials, this book is a valuable source of information for health care providers as well as cancer biologists interested in learning about melanoma and the significant advances made by immunotherapy.

ISBN: 9783319480664

Standard No.: 10.1007/978-3-319-48066-4doiSubjects--Topical Terms:

688049
Melanoma
--Immunotherapy.

LC Class. No.: RC280.M37

Dewey Class. No.: 616.9947706

Immunotherapy of melanoma[electronic resource] /
LDR:02575nam a2200313 a 4500 001 476908
003 DE-He213
005 20161221090658.0
006 m d
007 cr nn 008maaau
008 181208s2016 gw s 0 eng d
020 $a 9783319480664 $q (electronic bk.)
020 $a 9783319480657 $q (paper)
024 7 $a 10.1007/978-3-319-48066-4 $2 doi
035 $a 978-3-319-48066-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.M37
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.9947706 $2 23
090 $a RC280.M37 $b R851 2016
100 1 $a Rotte, Anand. $3 688047
245 1 0 $a Immunotherapy of melanoma $h [electronic resource] / $c by Anand Rotte, Madhuri Bhandaru.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xi, 434 p. : $b ill., digital ; $c 24 cm.
505 0 $a Preface -- Melanoma -- Tumor immunology -- Immune based drugs approved for treatment of melanoma -- Promising immunotherapeutic approaches in clinical trials -- Challenges of immunotherapy -- Index.
520 $a This book focusses on the different types of immunotherapeutics that are currently being used and developed for the treatment of melanoma. In recent years, immunotherapy has revolutionized the treatment of metastatic melanoma and other types of cancer. Discussing treatment options for melanoma and the success of immunotherapy along with the challenges of immunotherapy, this book covers epidemiology, susceptibility genes, and treatment recommendations from Society for Immunotherapy of Cancer, as well as immune based therapies such as aldesleukin, Intron-A, Sylatron, Yervoy, Opdivo, Keytruda, Imlygic, DC vaccines and adoptive cell therapy. The detailed information included on the key immune cells involved in anti-tumor immune response and immune-inhibitory mechanisms in tumor microenvironment will aid the understanding of tumor immunology. Both academic as well as industry-based researchers, developing novel anti-cancer therapies, will also benefit from the details of promising molecular targets and immunotherapeutic strategies under investigation. With 132 illustrations including synopsis tables for important information, over 1200 references (majority of which are openly accessible) and details of more than 150 ongoing clinical trials, this book is a valuable source of information for health care providers as well as cancer biologists interested in learning about melanoma and the significant advances made by immunotherapy.
650 0 $a Melanoma $x Immunotherapy. $3 688049
650 0 $a Melanoma $x Immunological aspects. $3 688050
650 0 $a Medicine. $3 373206
650 0 $a Cancer $x Research. $3 466126
650 0 $a Oncology. $3 205017
650 1 4 $a Biomedicine. $3 463454
650 2 4 $a Cancer Research. $3 463530
700 1 $a Bhandaru, Madhuri. $3 688048
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-48066-4
950 $a Biomedical and Life Sciences (Springer-11642)